Blog Archives

“MAPPING STUDIES” IN COST-UTILITY ANALYSES: NEW RECOMMENDATIONS FROM ISPOR TASK FORCE

OC.indd

Guidance for the Consistent Application of Appropriate Analytical Methods   Princeton, NJ—February 14, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good

Tagged with: , ,
Posted in Announcements, ISPOR News & Press, Value in Health

ISPOR RELEASES NEW TASK FORCE RECOMMENDATIONS FOR THE DEVELOPMENT OF CLINICIAN-REPORTED OUTCOME ASSESSMENTS

OC.indd

New Report Fills Long Standing Guidance Gap and Will Help Standardize ClinRO Assessments Princeton, NJ—February 13, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the

Tagged with: , ,
Posted in Announcements, ISPOR News & Press, Value in Health

MOVING TOWARD UNIVERSAL HEALTH CARE COVERAGE: EXPLORING POLICY TRENDS IN COUNTRIES RICH AND POOR

ViH_Cover_2016-12

Value in Health Series Examines Progress Toward Enacting an Integral Part of the Global Health Agenda Princeton, NJ—December 19, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a series of articles exploring trends in

Tagged with: , , , , , , ,
Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health

ACCOUNTING FOR FUTURE PRICE REDUCTIONS CAUSED BY INCREASING ADOPTION OF MEDICAL DEVICES: IMPACT ON HTAs

Value in Health - Sept-Oct 2016

Future Changes in Price and Uptake Affect Cost-Effectiveness Results  Princeton, NJ—October 10, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a report detailing a new modeling approach that explores the health technology assessment (HTA)

Tagged with: , , ,
Posted in Announcements, ISPOR News & Press, Value in Health

ISPOR TASK FORCE PROVIDES RECOMMENDATIONS ON THE COLLECTION OF HEALTH-STATE UTILITY DATA IN CLINICAL STUDIES

Value in Health - Sept-Oct 2016

Five Areas of Guidance Enable Optimum Health-State Utility Measurement  Princeton, NJ—October 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Task Force on Good Practices for Outcome Research—Measurement of Health-State Utility Values for Economic Models in Clinical Studies—has published

Tagged with: ,
Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health

ISPOR SPECIAL INTEREST GROUP RECOMMENDS CHANGES TO HEALTH TECHNOLOGY ASSESSMENTS FOR MOLECULAR DIAGNOSTICS

ViH Cover 2016_07-08

Issues Nine Specific Recommendations to Address Identified Challenges Princeton, NJ—August 30, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Medical Devices and Diagnostics Special Interest Group has completed a review of diagnostic-specific health technology assessment programs, identified elements representing

Tagged with: , , , ,
Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health

US HEALTH CARE SYSTEM BEGINS TO EMBRACE COST EFFECTIVENESS AS A CENTRAL COMPONENT OF “VALUE”

ViH Cover 2016_07-08

Value in Health Series Indicates We May Have Reached a Tipping Point  Princeton, NJ—August 29, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a series of articles suggesting that the application of cost-effectiveness analysis

Tagged with: , , , , , , , , ,
Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health

STUDY FINDS BEST-WORST SCALING COMPARABLE TO DISCRETE CHOICE EXPERIMENT IN ESTIMATING PATIENT PREFERENCES

Value in Health - June 2016 issue (Volume 19, Issue 4)

However, Risk Tolerance Thresholds Differ Between the Two Methods Princeton, NJ—July 25, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a study comparing the metrics obtained from profile-case best-worst scaling (BWS) with those from

Tagged with: , , , ,
Posted in Announcements, ISPOR Journals, ISPOR News & Press, Methodological Articles, Value in Health

As the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Value in Health provides a forum for researchers, health care decision makers, and policy makers to translate pharmacoeconomics and outcomes research into health care decisions. To learn more about Value in Health, please visit the Value in Health homepage.

Categories
Follow ISPOR
RSS FeedFriend me on FacebookFollow my company on LinkedInFollow me on TwitterWatch me on YouTube